The Biodefense Diplomacy Enhancement Act is currently in the early stages of the legislative process. It was introduced in the Senate and is now being reviewed by the Committee on Foreign Relations. There are no upcoming votes scheduled at this time.
Legislative Progress
Senate
House
President
Law
Could go either way
This bill has support from both parties and addresses a major security concern, but many foreign policy bills take a long time to move through the full Senate.
Key Points
The bill requires the State Department to work more closely with the NATO military alliance and other partner countries to handle biological threats. This includes sharing information about dangerous germs and making sure countries are ready to respond if a biological attack ever happens.
A new strategy would be created to find weaknesses in how the U.S. and its allies prepare for biological risks. The goal is to improve how countries detect threats and coordinate their emergency responses to keep people safe from weaponized diseases.
The policy also focuses on biotechnology exports. It aims to prevent sensitive technology used for medical research from being turned into biological weapons by other countries. This involves setting stricter rules on what equipment and research can be shared or sold overseas.
Government officials would have to give regular updates to Congress about their work. They must submit a formal plan within nine months and report on any new biological developments that could put the United States at risk.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
2 milestones2 actions
May 12, 2026Senate
Read twice and referred to the Committee on Foreign Relations.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
May 12, 2026
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
